Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Andrea C. Klaver"'
Publikováno v:
Translational Neurodegeneration, Vol 6, Iss 1, Pp 1-9 (2017)
Abstract Background Tau vaccination and administration of anti-tau antibodies can prevent pathology and cognitive impairment in transgenic mouse models of tauopathy, suggesting that therapies which increase anti-tau antibodies might slow the developm
Externí odkaz:
https://doaj.org/article/40d2e7973ff847a48c5316f18d5bd11b
Publikováno v:
Frontiers in Aging Neuroscience, Vol 10 (2018)
Autophagy removes both functional and damaged intracellular macromolecules from cells via lysosomal degradation. Three autophagic mechanisms, namely macroautophagy, chaperone-mediated autophagy (CMA), and microautophagy, have been described in mammal
Externí odkaz:
https://doaj.org/article/cb89f995a6e3466aaeb145d020703310
Autor:
Amanda C. Crisostomo, Loan Dang, Jyothi L. Digambaranath, Andrea C. Klaver, David A. Loeffler, Jeremiah J. Payne, Lynnae M. Smith, Adam L. Yokom, John M. Finke
Publikováno v:
Data in Brief, Vol 4, Iss C, Pp 650-658 (2015)
The data here consists of time-dependent experimental parameters from chemical and biophysical methods used to characterize Aβ monomeric reactants as well as soluble oligomer and amyloid fibril products from a slow (3–4 week) assembly reaction und
Externí odkaz:
https://doaj.org/article/70189ab93d914f0ea3b12dee76f4bd0a
Publikováno v:
Brain Research. 1683:12-16
Lysosome-associated membrane glycoprotein 2 (lamp2) plays critical roles in chaperone-mediated autophagy (CMA) and macroautophagy. Its isoform lamp2a is decreased in Parkinson’s disease (PD) substantia nigra. Mutations in the leucine-rich repeat ki
Publikováno v:
Translational Neurodegeneration, Vol 6, Iss 1, Pp 1-9 (2017)
Translational Neurodegeneration
Translational Neurodegeneration
Background Tau vaccination and administration of anti-tau antibodies can prevent pathology and cognitive impairment in transgenic mouse models of tauopathy, suggesting that therapies which increase anti-tau antibodies might slow the development and/o
Autor:
David A. Loeffler, Andrea C. Klaver
Publikováno v:
International Immunopharmacology. 52:227-229
Specific antibody concentrations are frequently measured in serum (and plasma and intravenous immunoglobulin) samples by enzyme-linked immunosorbent assay (ELISA). The standard negative control involves incubation of buffer alone on antigen-coated we
Publikováno v:
International Immunopharmacology. 28:1108-1112
The therapeutic effects of intravenous immunoglobulin (IVIG) products were recently studied in Alzheimer's disease (AD) patients. Pilot studies produced encouraging results but phase II and III trials gave disappointing results; a further study is in
Autor:
John M. Finke, Lynnae M. Smith, David A. Loeffler, Loan Dang, Adam L. Yokom, Amanda C. Crisostomo, Jeremiah J. Payne, Jyothi L. Digambaranath, Andrea C. Klaver
Publikováno v:
Data in Brief
Data in Brief, Vol 4, Iss C, Pp 650-658 (2015)
Data in Brief, Vol 4, Iss C, Pp 650-658 (2015)
The data here consists of time-dependent experimental parameters from chemical and biophysical methods used to characterize Aβ monomeric reactants as well as soluble oligomer and amyloid fibril products from a slow (3–4 week) assembly reaction und
Publikováno v:
Experimental Gerontology. 67:15-18
Phosphorylation of multiple amino acids on tau protein (“hyperphosphorylation”) is required for the development of tau pathology in Alzheimer's disease. Administration of anti-tau antibodies to transgenic “tauopathy mice” has been shown to re
Autor:
Adam L. Yokom, Lynnae M. Smith, Amanda C. Crisostomo, Andrea C. Klaver, Jyothi L. Digambaranath, Loan Dang, David A. Loeffler, Jeremiah J. Payne, John M. Finke
Publikováno v:
Analytical Biochemistry. 481:43-54
Surface plasmon resonance was used to investigate the kinetics, affinity, and specificity of binding between anti-Aβ (beta-amyloid) IgG antibodies and oligomeric Aβ. Two factors were needed to accurately characterize the IgG binding kinetics. First